FerGene Stock

www.fergene.comHealthcareFounded: 2019

FerGene is a gene therapy company dedicated to creating and delivering innovative solutions for bladder cancer. The company's goal is to harness the promise of gene therapy to develop a novel treatment for non-muscle invasive bladder cancer.

Register for Details

For more details on financing and valuation for FerGene, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for FerGene.

Register Today

Other companies like FerGene in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector